IMMUNOSENS Co. Ltd. announced that it has received a round of funding on July 26, 2023. The transaction included participation from new investor, Shimadzu Future Innovation Fund L.P., a fund co-managed by Global Brain Co., Ltd., and Shimadzu Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,332 JPY | -2.23% | -0.05% | +9.89% |
May. 10 | Shimadzu Corporation announces an Equity Buyback for 12,500,000 shares, representing 4.24% for ¥25,000 million. | CI |
May. 10 | Shimadzu Corporation authorizes a Buyback Plan. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.89% | 8.35B | |
-0.41% | 4.76B | |
-4.57% | 2.95B | |
+7.35% | 2.14B | |
-28.01% | 1.11B | |
-5.13% | 836M | |
-23.79% | 749M | |
-22.92% | 674M | |
-56.53% | 625M | |
-33.11% | 596M |
- Stock Market
- Equities
- 7701 Stock
- News Shimadzu Corporation
- IMMUNOSENS Co. Ltd. announced that it has received funding from Global Brain Co., Ltd., Shimadzu Corporation